Interaction between periodontitis and liver diseases (Review)
- Authors:
- Pengyu Han
- Dianxing Sun
- Jie Yang
-
Affiliations: The Liver Disease Diagnosis and Treatment Center of PLA, Bethune International Peace Hospital, Shijiazhuang, Hebei 050082, P.R. China, Department of Public Healthcare, Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China - Published online on: July 18, 2016 https://doi.org/10.3892/br.2016.718
- Pages: 267-276
-
Copyright: © Han et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, et al: Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 380:2163–2196. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Chung JH, Hwang HJ, Kim SH and Kim TH: Associations Between Periodontitis and Chronic Obstructive Pulmonary Disease; the 2010–2012 Korean National Health and Nutrition Examination Survey (KNHANES). J Periodontol. Feb 25–2016.(Epub ahead of print). View Article : Google Scholar | |
|
O'Dowd LK, Durham J, McCracken GI and Preshaw PM: Patients' experiences of the impact of periodontal disease. J Clin Periodontol. 37:334–339. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Gurav AN: The association of periodontitis and metabolic syndrome. Dent Res J (Isfahan). 11:1–10. 2014.PubMed/NCBI | |
|
Offenbacher S: Periodontal diseases: Pathogenesis. Ann Periodontol. 1:821–878. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Mealey BL and Rethman MP: Periodontal disease and diabetes mellitus. Bidirectional relationship. Dent Today. 22:107–113. 2003.PubMed/NCBI | |
|
Collin HL, Uusitupa M, Niskanen L, Kontturi-Närhi V, Markkanen H, Koivisto AM and Meurman JH: Periodontal findings in elderly patients with non-insulin dependent diabetes mellitus. J Periodontol. 69:962–966. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Murray CJ and Lopez AD: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 349:1269–1276. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Kuo LC, Polson AM and Kang T: Associations between periodontal diseases and systemic diseases: A review of the inter-relationships and interactions with diabetes, respiratory diseases, cardiovascular diseases and osteoporosis. Public Health. 122:417–433. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Scannapieco FA: Role of oral bacteria in respiratory infection. J Periodontol. 70:793–802. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
No authors listed: The World Health Report 1997 - conquering suffering, enriching humanity. World Health Forum. 18:248–260. 1997.PubMed/NCBI | |
|
Dave S, Batista EL Jr and Van Dyke TE: Cardiovascular disease and periodontal diseases: Commonality and causation. Compend Contin Educ Dent. 25(Suppl 1): 26–37. 2004.PubMed/NCBI | |
|
Reddy MS: Osteoporosis and periodontitis: Discussion, conclusions, and recommendations. Ann Periodontol. 6:214–217. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Aspalli SS, Shetty VS, Parab PG, Nagappa G, Devnoorkar A and Devarathnamma MV: Osteoporosis and periodontitis: Is there a possible link? Indian J Dent Res. 25:316–20. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Angulo P: Nonalcoholic fatty liver disease. N Engl J Med. 346:1221–1231. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Milić S and Stimac D: Nonalcoholic fatty liver disease/steatohepatitis: Epidemiology, pathogenesis, clinical presentation and treatment. Dig Dis. 30:158–162. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Angulo P and Lindor KD: Non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 17:S186–S190. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Liou I and Kowdley KV: Natural history of nonalcoholic steatohepatitis. J Clin Gastroenterol. 40(Suppl 1): S11–S16. 2006.PubMed/NCBI | |
|
Oh HJ, Kim TH, Sohn YW, Kim YS, Oh YR, Cho EY, Shim SY, Shin SR, Han AL, Yoon SJ, et al: Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease. Korean J Hepatol. 17:27–36. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Adams LA, Knuiman MW, Divitini ML and Olynyk JK: Body mass index is a stronger predictor of alanine aminotransaminase levels than alcohol consumption. J Gastroenterol Hepatol. 23:1089–1093. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Furuta M, Ekuni D, Yamamoto T, Irie K, Koyama R, Sanbe T, Yamanaka R, Morita M, Kuroki K and Tobe K: Relationship between periodontitis and hepatic abnormalities in young adults. Acta Odontol Scand. 68:27–33. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Saito T, Shimazaki Y, Koga T, Tsuzuki M and Ohshima A: Relationship between periodontitis and hepatic condition in Japanese women. J Int Acad Periodontol. 8:89–95. 2006.PubMed/NCBI | |
|
Morita T, Yamazaki Y, Fujiharu C, Ishii T, Seto M, Nishinoue N, Sasaki Y, Kawato T, Motohashi M and Maeno M: Serum γ-glutamyltransferase level is associated with periodontal disease independent of drinking habits in Japanese adults. Med Sci Monit. 20:2109–2116. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yoneda M, Naka S, Nakano K, Wada K, Endo H, Mawatari H, Imajo K, Nomura R, Hokamura K, Ono M, et al: Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. BMC Gastroenterol. 12:162012. View Article : Google Scholar : PubMed/NCBI | |
|
Friedman SL: Mechanisms of hepatic fibrogenesis. Gastroenterology. 134:1655–1669. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang DY and Friedman SL: Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatology. 56:769–775. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Murray KF and Carithers RL Jr: AASLD: AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology. 41:1407–1432. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Novacek G, Plachetzky U, Pötzi R, Lentner S, Slavicek R, Gangl A and Ferenci P: Dental and periodontal disease in patients with cirrhosis - role of etiology of liver disease. J Hepatol. 22:576–582. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Sponholz H, Naethbohm K, Brügmann E and Maass M: Correlations between chronic liver diseases and periodontal diseases with special reference to animal experiments. Stomatol DDR. 26:409–413. 1976.(In German). PubMed/NCBI | |
|
Movin S: Relationship between periodontal disease and cirrhosis of the liver in humans. J Clin Periodontol. 8:450–458. 1981. View Article : Google Scholar : PubMed/NCBI | |
|
Funatsu K, Yamada M, Kawishima Y, Nishida J, Ueno M, Ebihara Y, Mizuno Y, Oda M and Tsuchiya M: Microcirculatory disturbances of oral mucosa and periodontal disease in patients with liver cirrhosis. J Gastroenterol Hepatol. 4(Suppl 1): 99–102. 1989.PubMed/NCBI | |
|
Jaiswal G, Deo V, Bhongade M and Jaiswal S: Serum alkaline phosphatase: A potential marker in the progression of periodontal disease in cirrhosis patients. Quintessence Int. 42:345–348. 2011.PubMed/NCBI | |
|
Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Bosch FX, Ribes J, Díaz M and Cléries R: Primary liver cancer: Worldwide incidence and trends. Gastroenterology. 127(Suppl 1): S5–S16. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Anzola M: Hepatocellular carcinoma: Role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. J Viral Hepat. 11:383–393. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Fattovich G, Stroffolini T, Zagni I and Donato F: Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology. 127(Suppl 1): S35–S50. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Bralet MP, Régimbeau JM, Pineau P, Dubois S, Loas G, Degos F, Valla D, Belghiti J, Degott C and Terris B: Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases. Hepatology. 32:200–204. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Hujoel PP, Drangsholt M, Spiekerman C and Weiss NS: An exploration of the periodontitis-cancer association. Ann Epidemiol. 13:312–316. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Tezal M, Sullivan MA, Reid ME, Marshall JR, Hyland A, Loree T, Lillis C, Hauck L, Wactawski-Wende J and Scannapieco FA: Chronic periodontitis and the risk of tongue cancer. Arch Otolaryngol Head Neck Surg. 133:450–454. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Tezal M, Sullivan MA, Hyland A, Marshall JR, Stoler D, Reid ME, Loree TR, Rigual NR, Merzianu M, Hauck L, et al: Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 18:2406–2412. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kudo M, Chung H, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y and Matsunaga T: Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score. Hepatology. 40:1396–1405. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Luo KZ, Itamoto T, Amano H, Oshita A, Ushitora Y, Tanimoto Y, Ohdan H, Tashiro H and Asahara T: Comparative study of the Japan Integrated Stage (JIS) and modified JIS score as a predictor of survival after hepatectomy for hepatocellular carcinoma. J Gastroenterol. 43:369–377. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC and Williams R: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 60:646–649. 1973. View Article : Google Scholar : PubMed/NCBI | |
|
Tamaki N, Takaki A, Tomofuji T, Endo Y, Kasuyama K, Ekuni D, Yasunaka T, Yamamoto K and Morita M: Stage of hepatocellular carcinoma is associated with periodontitis. J Clin Periodontol. 38:1015–1020. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Maggs JR, Suddle AR, Aluvihare V and Heneghan MA: Systematic review: The role of liver transplantation in the management of hepatocellular carcinoma. Aliment Pharmacol Ther. 35:1113–1134. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Penn I: Hepatic transplantation for primary and metastatic cancers of the liver. Surgery. 110:726–734; discussion 734–735. 1991.PubMed/NCBI | |
|
Pichlmayr R, Weimann A and Ringe B: Indications for liver transplantation in hepatobiliary malignancy. Hepatology. 20(1 Pt 2): 33S–40S. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL and Roberts JP: Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology. 33:1394–1403. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A and Gennari L: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 334:693–699. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Guggenheimer J, Eghtesad B and Stock DJ: Dental management of the (solid) organ transplant patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 95:383–389. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Guggenheimer J, Mayher D and Eghtesad B: A survey of dental care protocols among US organ transplant centers. Clin Transplant. 19:15–18. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Guggenheimer J, Eghtesad B, Close JM, Shay C and Fung JJ: Dental health status of liver transplant candidates. Liver Transpl. 13:280–286. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Douglas LR, Douglass JB, Sieck JO and Smith PJ: Oral management of the patient with end-stage liver disease and the liver transplant patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 86:55–64. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Little JW and Rhodus NL: Dental treatment of the liver transplant patient. Oral Surg Oral Med Oral Pathol. 73:419–426. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Rustemeyer J and Bremerich A: Necessity of surgical dental foci treatment prior to organ transplantation and heart valve replacement. Clin Oral Investig. 11:171–174. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Silva Santos PS, Fernandes KS and Gallottini MH: Assessment and management of oral health in liver transplant candidates. J Appl Oral Sci. 20:241–245. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Aberg F, Helenius-Hietala J, Meurman J and Isoniemi H: Association between dental infections and the clinical course of chronic liver disease. Hepatol Res. 44:349–353. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Helenius-Hietala J, Meurman JH, Höckerstedt K, Lindqvist C and Isoniemi H: Effect of the aetiology and severity of liver disease on oral health and dental treatment prior to transplantation. Transpl Int. 25:158–165. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Bader G, Mesner M and Lejeune S: Oral surgery for liver transplant patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 84:5931997. View Article : Google Scholar : PubMed/NCBI | |
|
Golla K, Epstein JB and Cabay RJ: Liver disease: Current perspectives on medical and dental management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 98:516–521. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Valerin MA, Napeñas JJ, Brennan MT, Fox PC and Lockhart PB: Modified Child-Pugh score as a marker for postoperative bleeding from invasive dental procedures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 104:56–60. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Ward BB and Weideman EM: Long-term postoperative bleeding after dentoalveolar surgery in the pretransplant liver failure patient. J Oral Maxillofac Surg. 64:1469–1474. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Lins L, Bittencourt PL, Evangelista MA, Lins R, Codes L, Cavalcanti AR, Paraná R and Bastos J: Oral health profile of cirrhotic patients awaiting liver transplantation in the Brazilian Northeast. Transplant Proc. 43:1319–1321. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Sheehy EC, Roberts GJ, Beighton D and O'Brien G: Oral health in children undergoing liver transplantation. Int J Paediatr Dent. 10:109–119. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Barbero P, Garzino Demo MG, Milanesio M and Ottobrelli A: The dental assessment of the patient waiting for a liver transplant. Minerva Stomatol. 45:431–439. 1996.(In Italian). PubMed/NCBI | |
|
Kumar PS, Griffen AL, Barton JA, Paster BJ, Moeschberger ML and Leys EJ: New bacterial species associated with chronic periodontitis. J Dent Res. 82:338–344. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Kumar PS, Griffen AL, Moeschberger ML and Leys EJ: Identification of candidate periodontal pathogens and beneficial species by quantitative 16S clonal analysis. J Clin Microbiol. 43:3944–3955. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Fernández J and Gustot T: Management of bacterial infections in cirrhosis. J Hepatol. 56(Suppl 1): S1–S12. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Gustot T, Durand F, Lebrec D, Vincent JL and Moreau R: Severe sepsis in cirrhosis. Hepatology. 50:2022–2033. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Fernández J, Navasa M, Gómez J, Colmenero J, Vila J, Arroyo V and Rodés J: Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 35:140–148. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Fernández J, Acevedo J, Castro M, Garcia O, de Lope CR, Roca D, Pavesi M, Sola E, Moreira L, Silva A, et al: Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study. Hepatology. 55:1551–1561. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Fagiuoli S, Colli A, Bruno R, Craxì A, Gaeta GB, Grossi P, Mondelli MU, Puoti M, Sagnelli E, Stefani S, et al: 2011 AISF Single Topic Group: Management of infections pre- and post-liver transplantation: Report of an AISF consensus conference. J Hepatol. 60:1075–1089. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yilmaz O: The chronicles of Porphyromonas gingivalis: The microbium, the human oral epithelium and their interplay. Microbiology. 154:2897–2903. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Scannapieco FA, Bush RB and Paju S: Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review. Ann Periodontol. 8:38–53. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Beck J, Garcia R, Heiss G, Vokonas PS and Offenbacher S: Periodontal disease and cardiovascular disease. J Periodontol. 67(Suppl 10): 1123–1137. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Boggess KA, Madianos PN, Preisser JS, Moise KJ Jr and Offenbacher S: Chronic maternal and fetal Porphyromonas gingivalis exposure during pregnancy in rabbits. Am J Obstet Gynecol. 192:554–557. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Furusho H, Miyauchi M, Hyogo H, Inubushi T, Ao M, Ouhara K, Hisatune J, Kurihara H, Sugai M, Hayes CN, et al: Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice. J Gastroenterol. 48:1259–1270. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Raja M, Ummer F and Dhivakar CP: Aggregatibacter actinomycetemcomitans - a tooth killer? J Clin Diagn Res. 8:ZE13–ZE16. 2014.PubMed/NCBI | |
|
Narayanan SK, Nagaraja TG, Chengappa MM and Stewart GC: Leukotoxins of gram-negative bacteria. Vet Microbiol. 84:337–356. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Chen PB, Davern LB, Neiders ME, Reynolds HS and Zambon JJ: Analysis of in vitro lymphoproliferative responses and antibody formation following subcutaneous injection of Actinobacillus actinomycetemcomitans and Wolinella recta in a murine model. Oral Microbiol Immunol. 6:12–16. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Tuomainen AM, Jauhiainen M, Kovanen PT, Metso J, Paju S and Pussinen PJ: Aggregatibacter actinomycetemcomitans induces MMP-9 expression and proatherogenic lipoprotein profile in apoE-deficient mice. Microb Pathog. 44:111–117. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Hyvärinen K, Tuomainen AM, Laitinen S, Bykov IL, Törmäkangas L, Lindros K, Käkelä R, Alfthan G, Salminen I, Jauhiainen M, et al: Chlamydial and periodontal pathogens induce hepatic inflammation and fatty acid imbalance in apolipoprotein E-deficient mice. Infect Immun. 77:3442–3449. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, Guo J, Le Chatelier E, Yao J, Wu L, et al: Alterations of the human gut microbiome in liver cirrhosis. Nature. 513:59–64. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Goel A, Gupta M and Aggarwal R: Gut microbiota and liver disease. J Gastroenterol Hepatol. 29:1139–1148. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, et al: Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 499:97–101. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wiest R, Lawson M and Geuking M: Pathological bacterial translocation in liver cirrhosis. J Hepatol. 60:197–209. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
DiBaise JK, Zhang H, Crowell MD, Krajmalnik-Brown R, Decker GA and Rittmann BE: Gut microbiota and its possible relationship with obesity. Mayo Clin Proc. 83:460–469. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Socransky SS and Haffajee AD: Periodontal microbial ecology. Periodontol 2000. 38:135–187. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Goodson JM, Groppo D, Halem S and Carpino E: Is obesity an oral bacterial disease? J Dent Res. 88:519–523. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Boutaga K, Savelkoul PH, Winkel EG and van Winkelhoff AJ: Comparison of subgingival bacterial sampling with oral lavage for detection and quantification of periodontal pathogens by real-time polymerase chain reaction. J Periodontol. 78:79–86. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Saygun I, Nizam N, Keskiner I, Bal V, Kubar A, Açıkel C, Serdar M and Slots J: Salivary infectious agents and periodontal disease status. J Periodontal Res. 46:235–239. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
von Troil-Lindén B, Torkko H, Alaluusua S, Jousimies-Somer H and Asikainen S: Salivary levels of suspected periodontal pathogens in relation to periodontal status and treatment. J Dent Res. 74:1789–1795. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Koren O, Spor A, Felin J, Fåk F, Stombaugh J, Tremaroli V, Behre CJ, Knight R, Fagerberg B, Ley RE, et al: Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci USA. 108(Suppl 1): 4592–4598. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
O'Toole PW and Cooney JC: Probiotic bacteria influence the composition and function of the intestinal microbiota. Interdiscip Perspect Infect Dis. 2008:1752852008.PubMed/NCBI | |
|
Lentsch AB, Yoshidome H, Kato A, Warner RL, Cheadle WG, Ward PA and Edwards MJ: Requirement for interleukin-12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in mice. Hepatology. 30:1448–1453. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Lentsch AB, Yoshidome H, Cheadle WG, Miller FN and Edwards MJ: Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein-2 and KC. Hepatology. 27:1172–1177. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Gandoura S, Weiss E, Rautou PE, Fasseu M, Gustot T, Lemoine F, Hurtado-Nedelec M, Hego C, Vadrot N, Elkrief L, et al: Gene- and exon-expression profiling reveals an extensive LPS-induced response in immune cells in patients with cirrhosis. J Hepatol. 58:936–948. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Coant N, Simon-Rudler M, Gustot T, Fasseu M, Gandoura S, Ragot K, Abdel-Razek W, Thabut D, Lettéron P, Ogier-Denis E, et al: Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis. J Hepatol. 55:784–793. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Tazi KA, Quioc JJ, Saada V, Bezeaud A, Lebrec D and Moreau R: Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: Possible role of Akt and IRAK-M. J Hepatol. 45:280–289. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Galbois A, Thabut D, Tazi KA, Rudler M, Mohammadi MS, Bonnefont-Rousselot D, Bennani H, Bezeaud A, Tellier Z, Guichard C, et al: Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis. Hepatology. 49:175–184. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Thabut D, Massard J, Gangloff A, Carbonell N, Francoz C, Nguyen-Khac E, Duhamel C, Lebrec D, Poynard T and Moreau R: Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology. 46:1872–1882. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Byl B, Roucloux I, Crusiaux A, Dupont E and Devière J: Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients. Gastroenterology. 104:1492–1497. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Navasa M, Follo A, Filella X, Jiménez W, Francitorra A, Planas R, Rimola A, Arroyo V and Rodés J: Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality. Hepatology. 27:1227–1232. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Devière J, Content J, Denys C, Vandenbussche P, Schandene L, Wybran J and Dupont E: Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology. 11:628–634. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Le Moine O, Marchant A, De Groote D, Azar C, Goldman M and Devière J: Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis. Hepatology. 22:1436–1439. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Moreau R, Barrière E, Tazi KA, Lardeux B, Dargère D, Urbanowicz W, Poirel O, Chauvelot-Moachon L, Guimont MC, Bernuau D, et al: Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis. Hepatology. 36:1070–1078. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Tazi KA, Bièche I, Paradis V, Guichard C, Laurendeau I, Dargère D, Legrand A, Fay M, Pedruzzi E, Robin MA, et al: In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic rats. J Hepatol. 46:1075–1088. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Thabut D, Tazi KA, Bonnefont-Rousselot D, Aller M, Farges O, Guimont MC, Tellier Z, Guichard C, Ogier-Denis E, Poynard T, et al: High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats. Hepatology. 46:1893–1906. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Abu-Shanab A and Quigley EM: The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 7:691–701. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Madianos PN, Bobetsis YA and Kinane DF: Generation of inflammatory stimuli: How bacteria set up inflammatory responses in the gingiva. J Clin Periodontol. 32(Suppl 6): 57–71. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Shapira L, Champagne C, Van Dyke TE and Amar S: Strain-dependent activation of monocytes and inflammatory macrophages by lipopolysaccharide of Porphyromonas gingivalis. Infect Immun. 66:2736–2742. 1998.PubMed/NCBI | |
|
Hirschfeld M, Weis JJ, Toshchakov V, Salkowski CA, Cody MJ, Ward DC, Qureshi N, Michalek SM and Vogel SN: Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun. 69:1477–1482. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Malik R, Mookerjee RP and Jalan R: Infection and inflammation in liver failure: Two sides of the same coin. J Hepatol. 51:426–429. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Tritto G, Bechlis Z, Stadlbauer V, Davies N, Francés R, Shah N, Mookerjee RP, Such J and Jalan R: Evidence of neutrophil functional defect despite inflammation in stable cirrhosis. J Hepatol. 55:574–581. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Tilg H and Moschen AR: IL-1 cytokine family members and NAFLD: Neglected in metabolic liver inflammation. J Hepatol. 55:960–962. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Muñoz NM, Katz LH, Shina JH, Gi YJ, Menon VK, Gagea M, Rashid A, Chen J and Mishra L: Generation of a mouse model of T-cell lymphoma based on chronic LPS challenge and TGF-β signaling disruption. Genes Cancer. 5:348–352. 2014.PubMed/NCBI | |
|
Su GL, Klein RD, Aminlari A, Zhang HY, Steinstraesser L, Alarcon WH, Remick DG and Wang SC: Kupffer cell activation by lipopolysaccharide in rats: Role for lipopolysaccharide binding protein and toll-like receptor 4. Hepatology. 31:932–936. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Baffy G: Kupffer cells in non-alcoholic fatty liver disease: The emerging view. J Hepatol. 51:212–223. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Honda Y, Yamagiwa S, Matsuda Y, Takamura M, Ichida T and Aoyagi Y: Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in patients with primary biliary cirrhosis. J Hepatol. 47:404–411. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Yang SQ, Lin HZ, Lane MD, Clemens M and Diehl AM: Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA. 94:2557–2562. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Miura K, Yang L, van Rooijen N, Brenner DA, Ohnishi H and Seki E: Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice. Hepatology. 57:577–589. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol. 1:135–145. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Mattsson E, Verhage L, Rollof J, Fleer A, Verhoef J and van Dijk H: Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6. FEMS Immunol Med Microbiol. 7:281–287. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Wang ZM, Liu C and Dziarski R: Chemokines are the main proinflammatory mediators in human monocytes activated by Staphylococcus aureus, peptidoglycan, and endotoxin. J Biol Chem. 275:20260–20267. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Kengatharan KM, De Kimpe S, Robson C, Foster SJ and Thiemermann C: Mechanism of gram-positive shock: Identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. J Exp Med. 188:305–315. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Forner L, Nielsen CH, Bendtzen K, Larsen T and Holmstrup P: Increased plasma levels of IL-6 in bacteremic periodontis patients after scaling. J Clin Periodontol. 33:724–729. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM and van der Velden U: Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol. 71:1528–1534. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Morré SA, Ouburg S, Klinkenberg-Knol EC, Mulder CJ and Peña AS: The true ligand of the NOD2 receptor is peptidoglycan instead of lipopolysaccharide: A schematic representation of ligand-receptor interactions and NF-kappa B activation. Gastroenterology. 126:371–373. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Lichtman SN, Wang J, Schwab JH and Lemasters JJ: Comparison of peptidoglycan-polysaccharide and lipopolysaccharide stimulation of Kupffer cells to produce tumor necrosis factor and interleukin-1. Hepatology. 19:1013–1022. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Petit MD, Wassenaar A, van der Velden U, van Eden W and Loos BG: Depressed responsiveness of peripheral blood mononuclear cells to heat-shock proteins in periodontitis patients. J Dent Res. 78:1393–1400. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Tabeta K, Yamazaki K, Hotokezaka H, Yoshie H and Hara K: Elevated humoral immune response to heat shock protein 60 (hsp60) family in periodontitis patients. Clin Exp Immunol. 120:285–293. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Wick G: Atherosclerosis - an autoimmune disease due to an immune reaction against heat-shock protein 60. Herz. 25:87–90. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Yamazaki K, Ohsawa Y, Tabeta K, Ito H, Ueki K, Oda T, Yoshie H and Seymour GJ: Accumulation of human heat shock protein 60-reactive T cells in the gingival tissues of periodontitis patients. Infect Immun. 70:2492–2501. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Nencini C, Giorgi G and Micheli L: Protective effect of silymarin on oxidative stress in rat brain. Phytomedicine. 14:129–135. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Reddy BV, Sundari JS, Balamurugan E and Menon VP: Prevention of nicotine and streptozotocin treatment induced circulatory oxidative stress by bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione in diabetic rats. Mol Cell Biochem. 331:127–133. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Tüter G, Kurtiş B and Serdar M: Interleukin-1beta and thiobarbituric acid reactive substance (TBARS) levels after phase I periodontal therapy in patients with chronic periodontitis. J Periodontol. 72:883–888. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Tsai CC, Chen HS, Chen SL, Ho YP, Ho KY, Wu YM and Hung CC: Lipid peroxidation: A possible role in the induction and progression of chronic periodontitis. J Periodontal Res. 40:378–384. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Akalin FA, Baltacioğlu E, Alver A and Karabulut E: Lipid peroxidation levels and total oxidant status in serum, saliva and gingival crevicular fluid in patients with chronic periodontitis. J Clin Periodontol. 34:558–565. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Golz L, Memmert S, Rath-Deschner B, Jager A, Appel T, Baumgarten G, Götz W and Frede S: LPS from P. gingivalis and hypoxia increases oxidative stress in periodontal ligament fibroblasts and contributes to periodontitis. Mediators Inflamm. 2014:9862642014.PubMed/NCBI | |
|
Thomas B, Ramesh A, Suresh S and Prasad BR: A comparative evaluation of antioxidant enzymes and selenium in the serum of periodontitis patients with diabetes mellitus type 2. Contemp Clin Dent. 4:176–180. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Tamaki N, Tomofuji T, Ekuni D, Yamanaka R and Morita M: Periodontal treatment decreases plasma oxidized LDL level and oxidative stress. Clin Oral Investig. 15:953–958. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
D'Aiuto F, Nibali L, Parkar M, Patel K, Suvan J and Donos N: Oxidative stress, systemic inflammation, and severe periodontitis. J Dent Res. 89:1241–1246. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Tamaki N, Tomofuji T, Ekuni D, Yamanaka R, Yamamoto T and Morita M: Short-term effects of non-surgical periodontal treatment on plasma level of reactive oxygen metabolites in patients with chronic periodontitis. J Periodontol. 80:901–906. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Chaudhary S, Gowda TM, Mehta DS and Kumar TAB: Comparative evaluation of plasma ROM levels in chronic periodontitis patients before and after non-surgical and surgical periodontal therapy: A clinical trial. J Indian Soc Periodontol. 18:140–144. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wei D, Zhang XL, Wang YZ, Yang CX and Chen G: Lipid peroxidation levels, total oxidant status and superoxide dismutase in serum, saliva and gingival crevicular fluid in chronic periodontitis patients before and after periodontal therapy. Aust Dent J. 55:70–78. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Zacharakis G, Koskinas J, Kotsiou S, Tzara F, Vafeiadis N, Papoutselis M, Maltezos E, Sivridis E and Papoutselis K: The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(−) hepatitis B infection: Association with liver disease progression. A prospective cohort study. J Hepatol. 49:884–891. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
van Zonneveld M, Honkoop P, Hansen BE, Niesters HG, Darwish Murad S, de Man RA, Schalm SW and Janssen HL: Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B. Hepatology. 39:804–810. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
El-Serag HB: Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 142:1264–1273.e1. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Alavian SM, Izadi M, Zare AA, Lankarani MM, Assari S and Vardi MM: Survey of the level of anti-HBs antibody titer in vaccinated Iranian general dentists. Spec Care Dentist. 28:265–270. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Mahboobi N, Porter SR, Karayiannis P and Alavian SM: Dental treatment as a risk factor for hepatitis B and C viral infection. A review of the recent literature. J Gastrointestin Liver Dis. 22:79–86. 2013.PubMed/NCBI |
